Immuno Oncology Assays Market; By Products (Consumables, Instruments and Software & Services); By Technology (Immunoassay, PCR, NGS, ISH, Flow Cytometry); By Indication (Colorectal Cancer, Lung Cancer, Bladder Cancer, Breast Cancer, Melanoma and Others); By End-user (Research Laboratories, Clinical Diagnostic Laboratories and Others); By Region (North America, Europe, Asia-Pacific, LAMEA): Global Forecasts 2017 To 2027

The Global Immuno Oncology Assays Market Size was valued at USD 3.8 Bn in 2020 and expected to reach USD 7.7Bn by 2027, with a growing CAGR of 12.5% during the forecast period.

Immuno oncology assays are used for diagnosis and detection of various cancerous diseases. The samples used for the detection are DNA/RNA, blood, tumor, and cells. The proteins circulating in the blood, cells in the blood, and circulating free DNA are detected by different assays. The increasing clinical trails in immunotherapies, usage of targeted therapy, and increasing demand for personalized medicine are the driving factors of the Immuno Oncology Assays market Growth.

Immuno oncology assays market

The development of new novel therapies and the ongoing innovative and research in the field on oncology intend to accelerate the market. Nevertheless, the increasing prevalence of various cancer cases promote the growth of the market. The high adoption rate of targeted therapy is one of the prominent driving factors for the market.

Many key players are on the verge of product launches and various acquisitions leading to promote the market value of Immuno oncology assay. For instance, on August 5, 2021, HTG Molecular Diagnostics, Inc. announced the launch of HTG Transcriptome Panel in the U.S. and Europe. This launch featured a panel to measure 20,000 mRNA targets with the HTG EdgeSeq technology. The awareness for healthy lifestyle, increasing drug costs, increase in awareness regarding various cancers, drives the growth of market. Moreover, growing alertness regarding healthy and disease free, increase in organized retail marketing, rise in diseased population are considerably the major factors that boost the growth of Immuno Oncology Assays Industry.

Immuno Oncology Assays Market Segmentation:

By Product & Service

  • Consumables
  • Instruments
  • Software & Services

By Technology

  • PCR
  • Immunoassay
  • NGS
  • ISH
  • Flow Cytometry

By Indication

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Bladder Cancer
  • Melanoma
  • Others

By End-user

  • Research Laboratories
  • Clinical Diagnostic Laboratories
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Based on product & service, consumables segment accounted the largest market share in 2020

Based on product & service, consumables segment has gained tremendous market share in 2020 and predicted to gain more during the forecast period. This is due to increase testing and usage of consumables for the frequent diagnosis and detection. The highly sensitive molecular techniques and the kits requires for the testing also propel the segment in the market. Product launches by key players also propel the segment in the market. For instance, on June 28, 2018, Thermo Fisher Scientific, announced the launch of Oncomine TCR Beta-SR Assay for immuno-oncology research to analyze T-cell clonality in the tumor microenvironment.

Based on application, PCR segment accounted for largest market shares in 2020

Based on application, PCR segment held the maximum share in 2020. The dominance is due to demand of easy, early, and accurate detection testing of various cancerous diseases. Late detection can be life threatening and so techniques like PCR and others are preferred for utmost clarity in the diagnosis.

Based on indication, lung cancer segment is the largest market shares in 2020

Based on indication, lung cancer segment held maximum market shares in 2020. This is due to the high number of lung cancers across the world. According to Cancer Prevention and Control, Centers for Disease Control and Prevention, about 218,520 new lung cancers were diagnosed in the year 2018 and about 142,080 people died from lung cancer in the same year.

Based on end-user, research laboratories segment accounted for largest market share.

Based on end-user, research laboratories segment was the largest market share in 2020 and expected to continue the dominance. The emergence of Immunotherapy and the increasing continuous research account for the growth in the market. Other factors driving the global market includes an increase in manufacturing units, research and development by the key players and the launches. Moreover, changing lifestyle and standards, adoption of immunotherapies has led to the growth of the market.

Based on geographical region, North America dominated the Immuno oncology assays market in 2020.

Based on region, North America dominated the market in 2020. This region has eventually promoted the use and demand for immuno oncology assays and technologies to detect the various cancer. The extensive research and development conducted in cancer diagnostics and the clinical trails of immunotherapy for cancer promote the growth of the market in the region. Highly established infrastructures and machineries enhance the research and development.

Further, increase in research and development centres, rising government spending on healthcare, growing disposable income in this region surge the demand for market. The high birth rate creates opportunity for key players for development of more high-quality products further enhancing the growth of market in this region. Asia pacific is accounted to hold a significant share in the market. The population and the high cancer prevalence in the region is expected to accelerate the market in the region. There are many cancer awareness programs arranged. For Instance, National Breast Cancer Foundation, Inc., announced October month as the breast cancer awareness month.

Company Profiles and Competitive Intelligence

The key players operating in the market are:

  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • NanoString Technologies, Inc.
  • Sartorius AG
  • HTG Molecular Diagnostics, Inc.
  • Merck Millipore
  • PerkinElmer, Inc.
  • Abbott Laboratories
  • Guardant Health, Inc.
  • bioMérieux SA
  • Myriad Genetics, Inc.
  • Other Prominent Key Players
  • Seegene Inc
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories, Inc.
  • Creative Biolabs
  • NMI Technologietransfer GmbH

The report also provides in-depth analysis of Immuno oncology assays market dynamics such as drivers, restraints, opportunities and challenges.


  • Rising prevalence of various cancers across the globe.
  • Increasing demand for personalized drug
  • Increasing demand for targeted therapies
  • Recent product launches


  • Concern of high capital requirement
  • Stringent regulatory operations


  • Increase in adoption of targeted therapies
  • Key players and rising number of mergers & acquisitions among companies to expand their portfolio in Immuno Oncology Assays Market


  • Low awareness of cancer immunotherapy

COVID-19 Impact on the Immuno Oncology Assays Market Analysis

The Covid-19 outbreak has experienced a negative impact on the industry as it has highly affected the industries in terms of growth, economy, health, and mental wellbeing of every individual. During covid-19 pandemic, the visit to doctors and speciality clinics were restricted, which hamper the demand of immuno oncology assays. This blocked the opportunity for the retailers and manufactures to increase their sale of Immuno oncology assays during the pandemic time. There was a disruption in manufacturing, supply chain facilities, and consumer spending due to financial crisis.

The report also provides in-depth analysis of key trends in immuno oncology assays market

  • Increase in government initiatives, development in innovative techniques and demand for detection of chronic disease, cancers and other acute disorders helps the Immuno Oncology Assays Market to sustain during pandemic.
  • Covid –19 has negatively affected Immuno Oncology Assays industry, as this pandemic induced lockdown across the globe. This results in decline the sales of Immuno Oncology Assays products in the market.  
  • Insufficient raw material and disruption in supply chain and manufacturing segment has badly affected the sales of Immuno Oncology Assays Market.

The report also provides in-depth analysis of recent news developments and investments

  • On May 05, 2021, Crown Bioscience (Crown Bio), acquired OcellO B.V., a privately owned contract research organization improving the development and research in the cancer treatment.
  • On March 02, 2020, Gilead acquired forty-seven for worth $4.9 Billion. The acquisition was for Immuno-Oncology Therapy in Multiple Clinical Studies for Diseases Including Acute Myeloid Leukemia, Diffuse Large B-Cell Lymphoma and Myelodysplastic Syndrome.

The unique insights provided by Immuno Oncology Assays Market report also includes the following:

  • In-depth value chain analysis
  • Opportunity mapping
  • Sector Snapshot
  • Key Players Positioning Matrix
  • Regulatory Scenario
  • Strategies Adopted-Benchmarking Heat Map
  • Market Trends
  • Covid-19 Impact Analysis
  • Product Comparison
  • Pre & Post COVID 19 Impacts on Immuno Oncology Market
  • Competitive Landscape

Frequently Asked Questions (FAQs)

The global immuno oncology assays market was valued at USD 3.8 Bn in 2020 and is anticipated to reach USD 7.7 Bn by 2027

The immuno oncology assays market is estimated to grow at a compound annual growth rate (CAGR) of 12.5% during 2021-2027

In the base year 2020, North America accounted for major share in the immuno oncology assays market

Increase in prevalence of cancer cases and disorders which drives the growth of global immuno oncology assays market.

Few key players include, but not limit up to: F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Illumina, Inc., NanoString Technologies, Inc., Sartorius AG, Agilent Technologies, Inc., HTG Molecular Diagnostics, Inc., QIAGEN N.V., Merck Millipore, PerkinElmer, Inc., Abbott Laboratories, Other Prominent Key Players

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

  1.  Introduction
    1. Product Outline
    2. What is Immuno Oncology Assays
    3. Analysis of Immuno Oncology Assays Market
    4. COVID -19 Impact
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Threats
  2. Immuno Oncology Assays Market by Product & Service
    1. Consumables
    2. Instruments
    3. Software & Services
  3. Immuno Oncology Assays Market by Technology
    1. PCR
    2. Immunoassay
    3. NGS
    4. ISH
    5. Flow Cytometry
  4. Immuno Oncology Assays Market by Indication
    1. Lung Cancer
    2. Breast Cancer
    3. Colorectal Cancer
    4. Bladder Cancer
    5. Melanoma
    6. Others
  5. Immuno Oncology Assays Market by End-user
    1. Research Laboratories
    2. Clinical Diagnostic Laboratories
    3. Others
  6. Regional Analysis
    1. North America
      1. US
      2. Canada
    2. Europe
      1. Germany
      2. UK
      3. France 
      4. Spain
      5. Italy
      6. Rest Of Europe
    3. Asia Pacific
      1. China
      2. India
      3. Japan
      4. Australia
      5. Rest Of Asia Pacific
    4. Latin America
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    5. Middle East and Africa
      1. GCC
      2. South Africa
      3. Rest of MEA
  7. Key Strategic Insights
  8. Market Analysis
    1. Opportunity Mapping
    2. Critical Success Factors
    3. Consumer Preferences
  9.  Key Market Trends / Recent Developments
  10. Competitive Scenario
    1. Mergers and Acquisitions
    2. Investments
    3. Joint Ventures
    4. New Product Launches
    5. Ranking of Key Players
  11. Key Global Players
    1. Thermo Fisher Scientific, Inc.
    2. F. Hoffmann-La Roche Ltd.
    3. Agilent Technologies, Inc.
    4. Illumina, Inc.
    5. NanoString Technologies, Inc.
    6. Sartorius AG
    7. HTG Molecular Diagnostics, Inc.
    8. QIAGEN N.V.
    9. Merck Millipore
    10. PerkinElmer, Inc.
    11. Abbott Laboratories
    12. Guardant Health, Inc.
    13. bioMérieux SA
    14. Myriad Genetics, Inc.
    16. Other Prominent Key Players

Choose License

License Type
Ask for Customization

Why Choose AllTheResearch?

  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on Quadrant Positioning of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports.Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.
Speak to Analyst

Quick Inquiry

Follow Us

Choose License

License Type
Ask for Customization